A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

Condition:   Premenopausal Breast CancerInterventions:   Drug: TAP-144-SR(6M);   Drug: TAP-144-SR(3M)Sponsor:   TakedaCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials